
Are Weight Loss Drugs Changing Our Brains? | Professor Giles Yeo
Notas del episodio
Lara Lewington sits down with leading Cambridge geneticist and obesity researcher Professor Giles Yeo to uncover the science, reality, and future of GLP-1 weight loss drugs like Ozempic and Mounjaro. From how these medications interact directly with hunger and reward circuits in the brain to the surprising biological truth behind muscle loss and "Ozempic face," Professor Yeo breaks down what actually happens when appetite is chemically switched off. Plus, we explore whether GLP-1s could protect against diseases beyond obesity, the reality of taking them long-term, and how continuous glucose monitors (CGMs) fit into everyday health tracking.
Special Offer: This episode is brought to you in partnership with Thrive. To take control of your health data with simple, painless at-home blood testing for blood sugar, inflammation, and more, visit https://thriva.co and use code BODYOFEVIDENCE for 20% off your first test or membership.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Todos los episodios de Lara Lewington’s Your Body of Evidence